Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants
A recombinant respiratory syncytial virus (RSV) fusion glycoprotein candidate vaccine (RSV-PreF) manufactured in Chinese hamster ovary cells was developed for immunization of pregnant women, to protect newborns against RSV disease through trans-placental antibody transfer. Traces of a host-cell prot...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis Group
2020-06-01
|
| Серии: | Human Vaccines & Immunotherapeutics |
| Предметы: | |
| Online-ссылка: | http://dx.doi.org/10.1080/21645515.2019.1693749 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
